Ipas, in collaboration with the International Federation of Gynecology and Obstetrics (FIGO) and MSI Reproductive Choices, hosted an event at the margins of the Global Conference on Health and Climate Change.
Que des individus se trouvent dans l’incapacité d’interrompre une grossesse non désirée en toute confiance et en toute sécurité est un défi qui perdure encore aujourd’hui pour garantir l’accès universel aux soins complets de santé sexuelle et reproductive.
Un reto continuo para garantizar acceso universal a los servicios de atención integral a la salud sexual y reproductiva es la incapacidad de las personas para interrumpir un embarazo no deseado con confianza y seguridad.
A continuing challenge in ensuring universal access to comprehensive sexual and reproductive health care is the inability of individuals to confidently and safely terminate an unwanted pregnancy. This framework for sustainable abortion care is Ipas’s response to that urgent need. Using a human-centered approach, it identifies steps for program design, action and evaluation—and recognizes that sustainable abortion care is dynamic and requires new thinking, new ways of collaborating and new approaches.
Esta guía fue creada para ayudar a gerentes de programas y prestadores de servicios de aborto seguro con la estimación de necesidades de los medicamentos e insumos médicos más esenciales para la prestación de esos servicios. Aunque existen muchas guías sobre la estimación de necesidades de diversos insumos necesarios para los servicios de salud reproductiva, esta guía aborda específicamente la estimación de necesidades de medicamentos para el aborto con medicamentos y de aspiradores para la aspiración manual endouterina. Los procesos descritos paso a paso en esta guía pueden utilizarse para calcular los requisitos de insumos para un programa nacional o para una unidad de salud, durante determinado plazo.
Ce guide a été conçu pour aider les gestionnaires de programmes et les prestataires de soins d’avortement sécurisé à prévoir l’approvisionnement en médicaments et en produits sanitaires essentiels nécessaires à dispensation de ces soins.
This guide is designed to assist safe abortion services program managers and providers in forecasting for the most critical medicines and medical supplies required for providing these services. While there are many guides for forecasting various reproductive health commodities, this guide specifically addresses forecasting for medical abortion drugs and vacuum aspirators. The step-by-step processes listed in this guide can be used to estimate the commodity requirements for a national program or for an individual service site for a given amount of time.
Este guia foi desenvolvido para ajudar os gestores de programas e provedores de serviços de aborto seguro a estimar os medicamentos e artigos médicos mais críticos necessários para a prestação desses serviços.
Ipas, in collaboration with the International Federation of Gynecology and Obstetrics (FIGO) and MSI Reproductive Choices, hosted an event at the margins of the Global Conference on Health and Climate Change.
This 12-page job aid supports efficient inventory management of misoprostol (and mifepristone, depending on the setting) and other maternal-health medicines. It defines sound inventory management practices that can help reduce stock-outs and oversupply situations, and is for use by staff in public health facilities, nongovernmental organizations (civil society organizations) and private for-profit clinics and hospitals.
Ipas’s mission to reduce deaths and injuries from unsafe abortion and to increase women’s ability to exercise their sexual and reproductive rights is comprehensive. This report provides a snapshot of the breadth of Ipas efforts, highlighting fiscal year 2014 (July 2013-June 2014) results.
